West Pharmaceutical Services reported $2.2M in Interest Expense on Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Baxter International BAX:US USD 109M 16M
Becton, Dickinson and BDX:US USD 104M 5M
Catalent CTLT:US USD 32M 0
Charles River Laboratories CRL:US USD 11.38M 7.67M
Cooper Companies COO:US USD 17.1M 6.3M
Dentsply International XRAY:US USD 14M 1000K
Icu Medical ICUI:US USD 21.15M 4.88M
Insulet PODD:US USD 9.2M 100K
Integra Lifesciences IART:US USD 12.81M 573K
IQVIA Holdings Inc IQV:US USD 108M 14M
Medtronic MDT:US USD 118M 7M
Meridian Bioscience VIVO:US USD 220K 36K
Merit Medical Systems MMSI:US USD 1.83M 483K
Repligen RGEN:US USD 329K 58K
West Pharmaceutical Services WST:US USD 2.2M 400K